ArticleFrontiers in pharmacology2024

A real-world study of adverse drug reactions of two isocitrate dehydrogenase inhibitor based on the US FDA adverse event reporting system and VigiAccess databases.

Mengmeng Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.